304.28
-3.14
(-1.02%)
At close: January 29 at 4:00:02 PM EST
302.85
-1.43
(-0.47%)
Pre-Market: 8:59:01 AM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 11 | 13 | 13 |
| Avg. Estimate | 5.88 | 6.58 | 23.48 | 26.07 |
| Low Estimate | 5.43 | 5.94 | 23.04 | 25.12 |
| High Estimate | 6.15 | 7.25 | 23.75 | 27.2 |
| Year Ago EPS | 4.38 | 5.73 | 20.88 | 23.48 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 9 | 12 | 12 |
| Avg. Estimate | 10.32B | 10.52B | 40.39B | 43.4B |
| Low Estimate | 9.68B | 10.1B | 39.49B | 41.59B |
| High Estimate | 11.61B | 11.64B | 41.76B | 44.58B |
| Year Ago Sales | 9.05B | 9.93B | 34.07B | 40.39B |
| Sales Growth (year/est) | 14.05% | 5.96% | 18.56% | 7.45% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 4.35 | 5.64 | 5.6 | 5.94 |
| EPS Actual | 4.38 | 5.73 | 5.86 | 6.01 |
| Difference | 0.03 | 0.09 | 0.26 | 0.07 |
| Surprise % | 0.73% | 1.68% | 4.67% | 1.23% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 5.88 | 6.58 | 23.48 | 26.07 |
| 7 Days Ago | 5.91 | 6.58 | 23.48 | 26.09 |
| 30 Days Ago | 5.91 | 6.58 | 23.48 | 26.09 |
| 60 Days Ago | 5.91 | 6.61 | 23.48 | 26.17 |
| 90 Days Ago | 5.88 | 6.63 | 23.47 | 26.26 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 1 | 1 |
| Up Last 30 Days | 1 | 4 | 1 | 1 |
| Down Last 7 Days | -- | 2 | -- | -- |
| Down Last 30 Days | -- | 5 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MOH | 34.30% | 14.82% | 12.47% | 10.99% |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 1/6/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 11/4/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 10/25/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 10/24/2024 |
| Maintains | Baird: Outperform to Outperform | 10/24/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 10/1/2024 |
Related Tickers
CNC Centene Corporation
63.91
-1.25%
CI The Cigna Group
303.31
+0.16%
HUM Humana Inc.
294.23
-2.93%
ELV Elevance Health, Inc.
400.30
-1.26%
NEUE NeueHealth, Inc.
7.34
-0.14%
ALHC Alignment Healthcare, Inc.
15.32
+0.66%
UNH UnitedHealth Group Incorporated
538.10
-0.81%
OSCR Oscar Health, Inc.
16.68
+2.46%
CVS CVS Health Corporation
56.90
-0.75%
CLOV Clover Health Investments, Corp.
4.4500
-3.05%